Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients harboring the A3243G point mutation or large-scale deletions of mitochondrial DNA

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 10, 2002, Pages 885-895

  Vielhaber, Stefan ^a   Varlamov, Dmitry A ^a   Kudina, Tatiana A ^a   Schröder, Rolf ^a   Kappes Horn, Karin ^a   Elger, Christian E ^a   Seibel, Martina ^a   Seibel, Peter ^a   Kunz, Wolfram S ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

A3243G point mutation; Cytochrome content; Large scale deletions; Mitochondrial DNA diseases; Mutation gene dose dependency; Skeletal muscle

Indexed keywords

CYTOCHROME; CYTOCHROME B; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXTERNAL OPHTHALMOPLEGIA; FEMALE; GENE DELETION; GENE DOSAGE; GENE MUTATION; HETEROPLASMY; HUMAN; KEARNS SAYRE SYNDROME; MALE; MELAS SYNDROME; MITOCHONDRIAL RESPIRATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SKELETAL MUSCLE;

EID: 0036794004     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.10.885     Document Type: Article

References (28)

1. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-1212
2. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns - Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy. Proc Natl Acad Sci USA 1989;86:7952-56
3. Chomyn A. The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics. Am J Hum Genet 1998;62:745-51
4. Leu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 2000;275:19198-19209
5. Schon EA, Koga Y, Davidson M, Moreas CT, King MP. The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: A model for pathogenesis. Biochim Biophys Acta 1992;1101:206-9
6. Flierl A, Reichmann H, Seibel P. Pathophysiology of the MELAS 3243 transition mutation. J Biol Chem 1997;272:27189-96
7. Börner GV, Zeviani M, Tiranti V, et al. Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Gen 2000:9:467-75
8. Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 1991;88:10614-18
9. Porteous WK, James AM, Sheard PW, et al. Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 1998;257:192-201
10. Yamamoto M, Clemens PR, Engel AG. Mitochondrial DNA deletions in mitochondrial cytopathies: Observations in 19 patients. Neurology 1991;41:1822-88
11. Fassati A, Bordoni A, Amboni P, et al. Chronic progressive external ophthalmoplegia: A correlative study of quantitative molecular data and histochemical nd biochemical profile. J Neurol Sci 1994;123: 140-46
12. Laforet P, Lombes A, Eymard B, et al. Chronic progressive external ophthalmoplegia with ragged-red fibers: Clinical, morphological and genetic investigations in 43 patients. Neuromuscul Disord 1995;5:399-413
13. Kiyomoto BH, Tengan CH, Moraes CT, Oliveira ASB, Gabbai AA. Mitochondrial DNA defects in Brazilian patients with chronic progressive external ophthalmoplegia. J Neurol Sci 1997;152:160-65
14. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNA-Leu(UUR) A-G(3243) mutation. A clinical and genetic study. Brain 1995; 118:721-34
15. Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 2000;47:381-84
16. Chinnery PF, Taylor DJ, Manners D, Styles P, Lodi R. No correlation between muscle A3243G mutation load and mitochondrial function in vivo. Neurology 200;56:1101-4
17. Schröder R, Vielhaber S, Wiedemann FR, et al. New insights into the metabolic consequences of large-scale mtDNA deletions: A quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropath Exp Neurol 2000; 59:353-60
18. Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 2000;47:179-85
19. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-37
20. Balaban RS, Mootha VK, Arai A. Spectroscopic determination of cytochrome c oxidase content in tissues containing myoglobin or hemoglobin. Anal Biochem 1996;237:274-78
21. Edwards CA, Bowyer JR, Trumpower BL. Function of the iron-sulfur protein of the cytochrome b-c1 segment in electron transfer reactions of the mitochondrial respiratory chain. J Biol Chem 1982; 257:3705-13
22. Wiedemann FR, Vielhaber S, Schröder S, Elger CE, Kunz WS. Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal Biochem 2000;279:55-60
23. Speck SH, Margoliash E. Characterization of the interaction of cytochrome c and mitochondrial ubiquinol-cytochrome c reductase. J Biol Chem 1984;259:1064-72
24. Dubowitz V. Muscle biopsy. A practical approach. Second edition. London: Baillière Tindall, 1985
25. Mariotti C, Savarese N, Suomalainen A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995;242:304-12
26. Hayashi J, Ohta S, Takai D, et al. Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. Biochem Biophys Res Commun 1993;197:1049-55
27. Petruzzella V, Moraes CT, Sano MC, Bonilla E, DiMauro S, Schon EA. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994;3:449-54
28. Koga Y, Koga A, Iwanaga R, et al. Single-fiber analysis of mitochondrial A3243G mutation in four different phenotypes Acta Neuropathol 2000;99:186-90